News Trial of VR therapy for myopia in kids starts in UK A therapy for myopia or short-sightedness in children based on virtual reality and a smartphone app is to be tested at UK trial sites.
News Changing Faces: pharma supplier, DTx, and non-profit hires f... A number of pharma-adjacent tech firms and non-profits announced personnel news in the month of November. We’ve rounded up some highlights below.
News Dopavision raises €12m for DTx to tackle myopia epidemic Digital therapeutics (DTx) startup Dopavision has raised funding to develop its lead product, an app designed to slow the progression of myopia – or short-sightedness – in children or adole
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
